Research / NVT / Fundamental state Inspectable configuration
State dimensions Filing 0001720635-23-000057 General Corporate
Debt relative to revenue 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
213.26% · OPTIONAL · VALID
Capex intensity 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.93% · OPTIONAL · VALID
Operating cash generation 70th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
16.88% · OPTIONAL · VALID
Share-count growth 89th Own-history percentile · N=18
Evidence method Yoy · gp.fundamentals.shares_outstanding
-0.41% · CORE · VALID
Revenue growth 61th Own-history percentile · N=18
Evidence method Yoy · gp.fundamentals.revenue
15.24% · CORE · VALID
Inventory pressure 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
54.13% · OPTIONAL · VALID
Gross margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
41.13% · CORE · VALID
Operating margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
18.19% · CORE · VALID
R&D intensity 55th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.13% · OPTIONAL · VALID
SBC intensity 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.71% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 10/10 normalized Level 3 Dec 31, 2021 10/10 normalized Level 3 Mar 31, 2022 10/10 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 10/10 normalized Level 3 Mar 31, 2023 10/10 normalized Level 3 Jun 30, 2023 10/10 normalized Level 3 Sep 30, 2023 10/10 normalized Level 3 Dec 31, 2023 10/10 normalized Level 3 Mar 31, 2024 10/10 normalized Level 3 Jun 30, 2024 10/10 normalized Level 3 Sep 30, 2024 10/10 normalized Level 3 Dec 31, 2024 10/10 normalized Level 3 Mar 31, 2025 10/10 normalized Level 3 Jun 30, 2025 10/10 normalized Level 3 Sep 30, 2025 10/10 normalized Level 3 Dec 31, 2025 10/10 normalized Level 3 Mar 31, 2026 10/10 normalized Level 3 Jun 30, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 241.44%
Current 213.26%
Delta -28.18% Capex Intensity Increased
Previous 1.89%
Current 1.93%
Delta 0.04% Cash Generation Increased
Previous 9.61%
Current 16.88%
Delta 7.27% Dilution Increased
Previous -0.43%
Current -0.41%
Delta 0.02% Growth Increased
Previous 10.38%
Current 15.24%
Delta 4.87% Inventory Pressure Decreased
Previous 59.19%
Current 54.13%
Delta -5.06% Margin Decreased
Previous 41.33%
Current 41.13%
Delta -0.21% Profitability Decreased
Previous 18.27%
Current 18.19%
Delta -0.08% R And D Intensity Decreased
Previous 2.18%
Current 2.13%
Delta -0.05% Sbc Intensity Increased
Previous 0.71%
Current 0.71%
Delta 0.00% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.